TherapeuticsMD Company Profile (NYSEMKT:TXMD)

About TherapeuticsMD

TherapeuticsMD logoTherapeuticsMD, Inc. is a women's healthcare product company. The Company's segment is creating and commercializing products for women. It is focused on conducting clinical trials necessary for regulatory approval and commercialization of advanced hormone therapy pharmaceutical products. Its drug candidates are created using its SYMBODA hormone technology, which enables the administration of hormones with high bioavailability alone or in combination. The Company manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter (OTC) vitamins. The Company's product line includes vitaTrue, vitaPearl, vitaMedMD Plus, vitaMedMD One Prenatal Multivitamin, vitaMedMD Plus Rx Prenatal Multivitamin, vitaMedMD One Rx Prenatal Multivitamin, vitaMedMD RediChew Rx Prenatal Multivitamin, vitaMedMD Iron 21/7, itaMedMD Menopause Relief with Lifenol Plus Bone Support, vitaMedMD Vitamin D3 50,000 IU, BocaGreenMD Prena1 Pearl and BocaGreenMD Prena1 Chew.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NYSEMKT
  • Symbol: TXMD
  • CUSIP:
Key Metrics:
  • Previous Close: $5.59
  • 50 Day Moving Average: $5.83
  • 200 Day Moving Average: $6.35
  • 52-Week Range: $4.39 - $9.29
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -13.31
  • P/E Growth: 0.00
  • Market Cap: $1.10B
  • Outstanding Shares: 196,580,000
Additional Links:
Companies Related to TherapeuticsMD:

Analyst Ratings

Consensus Ratings for TherapeuticsMD (NYSEMKT:TXMD) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $19.63

Analysts' Ratings History for TherapeuticsMD (NYSEMKT:TXMD)
Show:
DateFirmActionRatingPrice TargetDetails
11/7/2016GuggenheimReiterated RatingBuyView Rating Details
7/11/2016Noble FinancialReiterated RatingBuy$17.50View Rating Details
6/8/2016Jefferies Group LLCReiterated RatingBuyView Rating Details
4/4/2016Goldman Sachs Group, Inc. (The)Initiated CoverageBuy$10.00View Rating Details
12/8/2015Stifel NicolausBoost Price TargetBuy$10.00 -> $14.00View Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for TherapeuticsMD (NYSEMKT:TXMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016Q316($0.11)($0.13)$5.76 million$5.50 millionViewN/AView Earnings Details
8/4/2016Q216($0.10)($0.11)$5.63 million$4.40 millionViewN/AView Earnings Details
5/3/2016Q116($0.09)($0.11)$5.73 million$4.93 millionViewN/AView Earnings Details
2/25/2016Q415($0.10)($0.10)$5.33 million$5.63 millionViewListenView Earnings Details
11/4/2015Q315($0.12)($0.11)$5.01 million$5.19 millionViewN/AView Earnings Details
8/6/2015Q215($0.11)($0.16)$4.65 million$4.80 millionViewListenView Earnings Details
5/5/2015($0.10)($0.13)ViewN/AView Earnings Details
3/10/2015Q414($0.09)($0.10)$2.86 million$4.26 millionViewN/AView Earnings Details
11/6/2014Q3 14($0.08)($0.12)ViewN/AView Earnings Details
5/6/2014Q1 14($0.06)($0.06)$3.08 million$2.80 millionViewN/AView Earnings Details
3/3/2014Q213($0.06)($0.06)$2.72 million$2.90 millionViewN/AView Earnings Details
5/8/2013Q113($0.06)($0.06)$1.32 million$1.50 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for TherapeuticsMD (NYSEMKT:TXMD)
Current Year EPS Consensus Estimate: $-0.46 EPS
Next Year EPS Consensus Estimate: $-0.42 EPS

Dividends

Dividend History for TherapeuticsMD (NYSEMKT:TXMD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for TherapeuticsMD (NYSEMKT:TXMD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/11/2016Cooper C CollinsDirectorBuy16,000$6.23$99,680.00View SEC Filing  
8/25/2015Angus C RussellDirectorBuy13,500$5.98$80,730.00View SEC Filing  
6/8/2015Mitchell KrassanEVPSell30,000$8.18$245,400.00View SEC Filing  
5/12/2015Angus C RussellDirectorBuy35,000$6.15$215,250.00View SEC Filing  
5/11/2015Tommy G ThompsonChairmanBuy6,000$6.09$36,540.00View SEC Filing  
5/8/2015J Martin CarrollDirectorBuy10,000$6.11$61,100.00View SEC Filing  
11/21/2014Daniel A CartwrightCFOSell40,000$3.91$156,400.00View SEC Filing  
9/4/2014Tommy G ThompsonDirectorBuy1,757$5.44$9,558.08View SEC Filing  
6/5/2014Cooper C CollinsDirectorBuy20,000$3.84$76,800.00View SEC Filing  
5/9/2014Robert Lapenta, Jr.DirectorBuy5,000$3.66$18,300.00View SEC Filing  
5/8/2014Tommy ThompsonDirectorBuy14,000$3.57$49,980.00View SEC Filing  
3/26/2014Brian BernickDirectorSell421,268$6.70$2,822,495.60View SEC Filing  
3/26/2014John C.K. Iv MilliganInsiderSell353,412$6.70$2,367,860.40View SEC Filing  
3/26/2014Robert FinizioCEOSell982,053$6.70$6,579,755.10View SEC Filing  
3/10/2014Mitchell KrassanEVPSell7,500$7.73$57,975.00View SEC Filing  
2/26/2014John C.K. Iv MilliganPresidentSell25,000$6.31$157,750.00View SEC Filing  
2/21/2014Robert FinizioCEOSell50,000$6.17$308,500.00View SEC Filing  
2/12/2014Brian BernickDirectorSell31,250$6.16$192,500.00View SEC Filing  
1/30/2014John C.K. Iv MilliganInsiderSell25,000$6.16$154,000.00View SEC Filing  
1/23/2014Robert G FinizioCEOSell50,000$5.70$285,000.00View SEC Filing  
1/13/2014Mitchell KrassanEVPSell7,500$5.73$42,975.00View SEC Filing  
1/8/2014Brian BernickDirectorSell31,250$5.13$160,312.50View SEC Filing  
8/26/2013Brian BernickInsiderSell1,600,000$1.55$2,480,000.00View SEC Filing  
8/26/2013Jules A MusingDirectorBuy5,282$2.15$11,356.30View SEC Filing  
6/14/2013Cooper C CollinsDirectorSell2,631,579$1.75$4,605,263.25View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for TherapeuticsMD (NYSEMKT:TXMD)
DateHeadline
News IconTechnical Trading: Focus on Shares of TherapeuticsMD Inc (TXMD) - Davidson Register (NYSEMKT:TXMD)
davidsonregister.com - February 21 at 4:31 PM
News IconStock on Analysts Radar: TherapeuticsMD Inc (NYSEMKT:TXMD ... - Post Registrar (NYSEMKT:TXMD)
postregistrar.com - February 20 at 7:24 PM
istreetwire.com logoStocks Highlights: Flowserve Corporation (FLS), 8×8, Inc. (EGHT), TherapeuticsMD, Inc. (TXMD) - iStreetWire (NYSEMKT:TXMD)
istreetwire.com - February 18 at 9:24 AM
News IconNarrowing in on the Numbers for TherapeuticsMD, Inc. (AMEX:TXMD) - Sherwood Daily (NYSEMKT:TXMD)
sherwooddaily.com - February 17 at 6:49 PM
News IconTherapeuticsMD, Inc. (TXMD): Analysts bet a 477.25 percent change in price - Post Analyst (NYSEMKT:TXMD)
postanalyst.com - February 17 at 6:49 PM
News IconBrokers Watch List: TherapeuticsMD, Inc. (NYSEMKT:TXMD ... - The Newburgh Press (NYSEMKT:TXMD)
newburghpress.com - February 17 at 6:49 PM
News IconStock Levels in Review for TherapeuticsMD Inc. (TXMD) - Benton Bulletin (NYSEMKT:TXMD)
bentonbulletin.com - February 17 at 6:49 PM
finance.yahoo.com logoTherapeuticsMD Announces Webcast of Investor Day on March 1 (NYSEMKT:TXMD)
finance.yahoo.com - February 16 at 8:20 PM
finance.yahoo.com logoTherapeuticsMD Announces Webcast of Investor Day on March 1 (NYSEMKT:TXMD)
finance.yahoo.com - February 16 at 8:20 PM
finance.yahoo.com logoTherapeuticsMD Announces Webcast of Investor Day on March 1 (NYSEMKT:TXMD)
finance.yahoo.com - February 16 at 8:20 PM
News IconStock Volatility Review for TherapeuticsMD, Inc. (AMEX:TXMD) - Midway Monitor (NYSEMKT:TXMD)
midwaymonitor.com - February 15 at 6:41 AM
News IconTechnical Roundup On Two Stocks InvenSense, Inc. (INVN ... - Post Analyst (NYSEMKT:TXMD)
postanalyst.com - February 15 at 6:41 AM
News IconAverage Directional Index Review for TherapeuticsMD Inc. (TXMD) - BVN (NYSEMKT:TXMD)
bvnewsjournal.com - February 15 at 6:41 AM
News IconTechnical Roundup On Two Stocks WCI Communities, Inc. (WCIC), TherapeuticsMD, Inc. (TXMD) - Post Analyst (NYSEMKT:TXMD)
postanalyst.com - February 11 at 6:02 AM
News IconForward Earnings Estimate of TherapeuticsMD, Inc.(TXMD) - Highland Mirror (NYSEMKT:TXMD)
www.highlandmirror.com - February 11 at 6:02 AM
capitalcube.com logoTherapeuticsMD, Inc. breached its 50 day moving average in a Bearish Manner : TXMD-US : February 10, 2017 (NYSEMKT:TXMD)
www.capitalcube.com - February 11 at 6:02 AM
finance.yahoo.com logoTherapeuticsMD to Host Fourth Quarter and Year End 2016 Financial Results Conference Call and Webcast on February 23 (NYSEMKT:TXMD)
finance.yahoo.com - February 10 at 6:16 AM
News IconStock Concentration on Shares of TherapeuticsMD, Inc. (AMEX:TXMD) - Midway Monitor (NYSEMKT:TXMD)
midwaymonitor.com - February 9 at 6:21 AM
istreetwire.com logoWorth Watching Stocks: TherapeuticsMD, Inc. (TXMD), PVH Corp. (PVH), Waddell & Reed Financial, Inc. (WDR) - iStreetWire (NYSEMKT:TXMD)
istreetwire.com - February 6 at 11:12 PM
News IconStock Price of TherapeuticsMD, Inc. (TXMD) Increases 3.36% - Morning Outlook (NYSEMKT:TXMD)
www.morningoutlook.com - February 6 at 11:12 PM
News IconFinancial Review of TherapeuticsMD, Inc. (AMEX:TXMD) - The Newburgh Press (NYSEMKT:TXMD)
newburghpress.com - February 4 at 5:46 AM
4-traders.com logoTherapeuticsMD : Announces Investor Day on March 1 (NYSEMKT:TXMD)
www.4-traders.com - February 3 at 6:26 AM
News IconEarnings Forecast Research on TherapeuticsMD, Inc. (TXMD) - Morning Outlook (NYSEMKT:TXMD)
www.morningoutlook.com - February 1 at 7:08 AM
News IconStock Survey: Viewing Levels for TherapeuticsMD, Inc. (AMEX:TXMD) - The Tribune (NYSEMKT:TXMD)
lakecitytribune.com - January 30 at 10:40 AM
News IconTechnical Buzz on TherapeuticsMD, Inc. (AMEX:TXMD) - The Tribune (NYSEMKT:TXMD)
lakecitytribune.com - January 29 at 2:24 AM
News IconWilliams %R Check on Shares of TherapeuticsMD Inc. (TXMD) - Rives Journal (NYSEMKT:TXMD)
rivesjournal.com - January 29 at 2:24 AM
News IconEquity Research Analysts Peer Into Their Crystal Ball For TherapeuticsMD, Inc. (:TXMD) - Aiken Advocate (NYSEMKT:TXMD)
aikenadvocate.com - January 28 at 7:21 AM
istreetwire.com logoStocks Buzz: TherapeuticsMD, Inc. (TXMD), DDR Corp. (DDR), LKQ Corporation (LKQ) - iStreetWire (NYSEMKT:TXMD)
istreetwire.com - January 28 at 7:21 AM
News IconJust the Facts on TherapeuticsMD, Inc. (TXMD) - StockNewsJournal (NYSEMKT:TXMD)
stocknewsjournal.com - January 28 at 7:21 AM
News IconGofen Glossberg Il Cuts Position in Celgene Corporation (CELG) by $50193032 (NYSEMKT:TXMD)
vgtoday.net - January 25 at 8:03 AM
News IconTechnical Toolbox: Investor Focus on TherapeuticsMD Inc. (TXMD) - Sherwood Daily (NYSEMKT:TXMD)
sherwooddaily.com - January 25 at 8:03 AM
istreetwire.com logoStocks Highlights: Ross Stores, Inc. (ROST), TherapeuticsMD, Inc. (TXMD), Lamb Weston Holdings, Inc. (LW) - iStreetWire (NYSEMKT:TXMD)
istreetwire.com - January 25 at 8:03 AM
News IconWall Street Holds Inauguration Gains, How Did This Stock Fare: TherapeuticsMD, Inc. (:TXMD) - Wall Street Beacon (NYSEMKT:TXMD)
wsbeacon.com - January 22 at 5:01 AM
News IconTherapeuticsMD, Inc. (NYSEMKT:TXMD) Insider Ownership stands at 24.8 - The Newburgh Press (NYSEMKT:TXMD)
newburghpress.com - January 20 at 7:21 AM
finance.yahoo.com logoTherapeuticsMD Announces Investor Day on March 1 (NYSEMKT:TXMD)
finance.yahoo.com - January 20 at 7:21 AM
News IconDownward Trend Continues as Stock Can't Find Its Footing: TherapeuticsMD, Inc. (:TXMD) - Wall Street Beacon (NYSEMKT:TXMD)
wsbeacon.com - January 19 at 6:04 AM
News IconUpside Alert: Delving into Shares of TherapeuticsMD, Inc. (:TXMD) - Prospect Journal (NYSEMKT:TXMD)
prospectjournal.com - January 16 at 8:08 PM
istreetwire.com logoTrader Alert: Adobe Systems Incorporated (ADBE), TherapeuticsMD, Inc. (TXMD), Total System Services, Inc. (TSS) - iStreetWire (NYSEMKT:TXMD)
istreetwire.com - January 16 at 12:39 PM
News IconTherapeuticsMD, Inc. (NYSEMKT:TXMD) Closed the Last Trading Session with decrease of -2.98% - The Newburgh Press (NYSEMKT:TXMD)
newburghpress.com - January 10 at 3:28 AM
capitalcube.com logoTherapeuticsMD, Inc. – Value Analysis (NYSE MKT:TXMD) : January 6, 2017 (NYSEMKT:TXMD)
www.capitalcube.com - January 7 at 6:16 AM
capitalcube.com logoTherapeuticsMD, Inc. breached its 50 day moving average in a Bullish Manner : TXMD-US : January 5, 2017 (NYSEMKT:TXMD)
www.capitalcube.com - January 6 at 6:19 AM
finance.yahoo.com logoTherapeuticsMD to Present at 35th Annual J.P. Morgan Healthcare Conference on January 11 (NYSEMKT:TXMD)
finance.yahoo.com - January 4 at 7:24 AM
News IconAnalysts Keeping an Eye on: TherapeuticsMD Inc (NYSEMKT:TXMD ... - Post Registrar (NYSEMKT:TXMD)
postregistrar.com - January 2 at 8:08 PM
News IconWatching Stock Levels for TherapeuticsMD, Inc. (AMEX:TXMD) - Wall Street Beacon (NYSEMKT:TXMD)
wsbeacon.com - December 31 at 3:05 AM
News IconStock in Focus: TherapeuticsMD, Inc. (AMEX:TXMD) - Wall Street Beacon (NYSEMKT:TXMD)
wsbeacon.com - December 28 at 10:48 PM
istreetwire.com logoMomentum Stocks: Marsh & McLennan Companies, Inc. (MMC), TherapeuticsMD, Inc. (TXMD), JetBlue Airways ... - iStreetWire (NYSEMKT:TXMD)
istreetwire.com - December 27 at 8:00 PM
News IconWatching the Levels: TherapeuticsMD, Inc. (AMEX:TXMD) - Wall Street Beacon (NYSEMKT:TXMD)
wsbeacon.com - December 23 at 10:28 PM
News IconWatching Technical Positions on TherapeuticsMD Inc. (TXMD) - Yankee Analysts (NYSEMKT:TXMD)
yankeeanalysts.com - December 20 at 10:25 PM
News IconCompany Stock Focus on TherapeuticsMD, Inc. (AMEX:TXMD) - Business Daily Leader (NYSEMKT:TXMD)
businessdailyleader.com - December 20 at 5:23 PM
News IconFocus on RSI and CCI Levels: TherapeuticsMD Inc. (TXMD) - Yankee Analysts (NYSEMKT:TXMD)
yankeeanalysts.com - December 20 at 5:23 PM

Social

What is TherapeuticsMD's stock symbol?

TherapeuticsMD trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "TXMD."

Where is TherapeuticsMD's stock going? Where will TherapeuticsMD's stock price be in 2017?

4 analysts have issued twelve-month target prices for TherapeuticsMD's stock. Their predictions range from $10.00 to $33.00. On average, they anticipate TherapeuticsMD's stock price to reach $19.63 in the next year.

How do I buy TherapeuticsMD stock?

Shares of TherapeuticsMD can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of TherapeuticsMD stock cost?

One share of TherapeuticsMD stock can currently be purchased for approximately $5.59.


Last Updated on 2/22/2017 by MarketBeat.com Staff